ATA109189A -
A NEW CRYSTAL FORM OF THE HYDROCHLORIDE SALT OF THE H2 ANTAGONIST N- (2 - (((5- (DIMETHYLAMINO) -METHYL) -2-FURANYL) -ME HYL) -THIO) -ÄTHYL-N1-METHYL-2-NITRO- 1, 1-ETHENEDINE (RANITIDINE)
- Google Patents
A NEW CRYSTAL FORM OF THE HYDROCHLORIDE SALT OF THE H2 ANTAGONIST N- (2 - (((5- (DIMETHYLAMINO) -METHYL) -2-FURANYL) -ME HYL) -THIO) -ÄTHYL-N1-METHYL-2-NITRO- 1, 1-ETHENEDINE (RANITIDINE)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0422281Aexternal-prioritypatent/AT389696B/en
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to AT109189ApriorityCriticalpatent/AT402069B/en
Publication of ATA109189ApublicationCriticalpatent/ATA109189A/en
Application grantedgrantedCritical
Publication of AT402069BpublicationCriticalpatent/AT402069B/en
AT109189A1980-10-011989-05-08A novel crystalline form of the hydrochloride salt of the h2 antagonist n-(2-(((5-(dimethylamino)-methyl)-2- furanyl)methyl)thio)ethyl-n1-methyl-2-nitro-1,1- ethenediamine (ranitidine)
AT402069B
(en)
A novel crystalline form of the hydrochloride salt of the h2 antagonist n-(2-(((5-(dimethylamino)-methyl)-2- furanyl)methyl)thio)ethyl-n1-methyl-2-nitro-1,1- ethenediamine (ranitidine)
METHOD FOR PRODUCING THE HYDROCHLORIDE SALT OF THE H2 ANTAGONIST N- (2 - (((5- (DIMETHYLAMINO) METHYL) -2-FURANYL) -METHYL) -THIO) - | THYL-N1-METHY -2-NITRO-1,1 -AETHENDIAMIN
A novel crystalline form of the hydrochloride salt of the h2 antagonist n-(2-(((5-(dimethylamino)-methyl)-2- furanyl)methyl)thio)ethyl-n1-methyl-2-nitro-1,1- ethenediamine (ranitidine)
A novel crystalline form of the hydrochloride salt of the h2 antagonist n-(2-(((5-(dimethylamino)-methyl)-2- furanyl)methyl)thio)ethyl-n1-methyl-2-nitro-1,1- ethenediamine (ranitidine)
METHOD FOR PRODUCING THE HYDROCHLORIDE SALT OF THE H2 ANTAGONIST N- (2 - (((5- (DIMETHYLAMINO) METHYL) -2-FURANYL) -METHYL) -THIO) - | THYL-N1-METHY -2-NITRO-1,1 -AETHENDIAMIN
A process for the preparation of a pharmaceutical composition comprising a physical form of N- [4- [5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl] -3-methoxybenzoyl] -2-methylbenzenesulfonamide
PROCEDURE FOR THE PREPARATION OF THE THERAPEUTIC ACTIVE CRYSTALLINIC, HYDRATIZED FORM, DESCRIBED "FORM D", OF THE SODIUM SALT OF SYN-ISOMER 3-ACETOXYMETHYL-7- (2- (2-AMINO-4-THIAZOLYL) -2HYZOLYL) -2 CEF-3-em-4-CARB.
A PROCEDURE FOR THE PREPARATION OF A RACEMIC OR OPTICALLY ACTIVE COMPOUND OF OXAZOLYCIN-2,4-DIONA 5-SUBSTITUTED INTERMEDIATE COMPOUND FOR THE SAME AND PROCEDURE FOR PREPARING STARTING COMPOUNDS FOR SUCH PROCEDURE
A NEW CRYSTAL FORM OF THE HYDROCHLORIDE SALT OF THE H2 ANTAGONIST N- (2 - (((5- (DIMETHYLAMINO) -METHYL) -2-FURANYL) -ME HYL) -THIO) -ÄTHYL-N1-METHYL-2-NITRO- 1, 1-ETHENEDINE (RANITIDINE)
RACEMIC AND OPTICALLY ACTIVE FORMS OF 2- (4-BI-PHENYLYL) -N- (DIETHYLAMINOALCOYL) -PROPIONAMIDE, THEIR SALTS, THEIR PREPARATION AND THEIR USE AS SPASMOLYTIC AGENTS
METHOD OF ANALOGUE FOR THE PREPARATION OF N- (2 - ((5- (DIMETHYLAMINO-METHYL) -2-FURANYL) -METHYLTHIO) -ETHYL) -N '- (3,4-METHYLENDIOXYBENZYL) -2-NITRO-1,1-ETH